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ABSTRACT  26 
Purpose: The intensity of exercise-induced pain (EIP) reflects the metabolic environment in 27 
the exercising muscle, so during endurance exercise this may inform the intelligent regulation 28 
of work rate. Conversely, the acute debilitating effects of EIP on motor unit recruitment could 29 
impair the estimation of force produced by the muscle and impair judgement of current 30 
exercise intensity. This study investigated whether muscle pain that feels like EIP, 31 
administered via intramuscular injection of hypertonic saline, interferes with the ability to 32 
accurately reproduce torque in a muscle group relevant to locomotive exercise. Methods: On 33 
separate days, fourteen participants completed an isometric torque reproduction task of the 34 
knee extensors. Participants were required to produce torque at 15 and 20% maximal 35 
voluntary torque (MVIT), without visual feedback before (Baseline), during (Pain/No Pain), 36 
and after (Recovery) an injection of 0.9% isotonic saline (Control) or 5.8% hypertonic saline 37 
(Experimental) into the vastus lateralis of the right leg. Results: An elevated reported 38 
intensity of pain, and a significantly increased variance in mean contraction torque at both 39 
15% (P=0.049) and 20% (P=0.002) MVIT was observed in the Experimental compared to the 40 
Control condition. Both 15 and 20% target torques were performed at a similar pain intensity 41 
in the Experimental condition (15% MVIT, 4.2 ± 1.9; 20% MVIT, 4.5 ± 2.2; P>0.05). 42 
Conclusion: These findings demonstrate that the increased muscle pain from the injection of 43 
hypertonic saline impeded accurate reproduction of knee extensor torque. These findings 44 
have implications for the detrimental impact of EIP on exercise regulation and endurance 45 







New & Noteworthy 51 
We provide novel data demonstrating that the presence of muscle pain interferes with 52 
estimations of torque produced by the knee extensors, which could impair judgement of 53 
work-rate during endurance exercise. The novelty of our study is in the application of the 54 
hypertonic saline experimental model into a quadriceps muscle during short, submaximal 55 
isometric contractions at an intensity that provides a more translatable assessment of the 56 
impact of exercise-induced pain on work-rate regulation during whole-body exercise.  57 
 58 




















Exercise-induced pain (EIP) increases linearly with exercise intensity and duration (9), and 77 
has been suggested to provide useful sensory feedback about the relative strain of exercising 78 
muscles (7, 27, 31). During intense and fatiguing muscle contractions, nociceptors of Group 79 
III and IV muscle afferents become sensitised and activated by an accumulation of 80 
metabolites which induce the perception of EIP, but are also implicated in peripheral fatigue 81 
and the description of its perception (31, 38). Resultantly, EIP is often associated with other 82 
physiological and psychological factors of fatigue, and has been suggested to independently 83 
exacerbate or contribute to the development of fatigue (27). A change in muscle torque 84 
complexity, which is suggested to reflect the adaptability of the neuromuscular system and is 85 
reduced during fatiguing maximal and submaximal isometric contractions (34), could provide 86 
a non-invasive method to evaluate the fatiguing effect of EIP.  87 
 88 
During whole-body exercise, sensations of EIP may facilitate conscious control of 89 
homeostatic disturbance during exercise by enabling the intelligent regulation of available 90 
energetic resources (i.e. pacing) (12, 27, 54). However, the relationship between EIP and 91 
fatigue is likely more complex since it also causes various acute debilitating effects 92 
associated with motor unit recruitment (17) and, as a protective mechanism, restricts 93 
movement to reduce pain. Consequentially, whilst EIP may provide insight about the 94 
metabolic environment in the exercising muscle, these potentially detrimental adaptations 95 
may reduce the accuracy of estimations of work done and/or force applied by the muscle, 96 
which could impair pacing decisions during whole-body exercise.  97 
 98 
Supressing the unpleasant sensations associated with intense exercise may allow a higher 99 
exercise-intensity to be tolerated and sustained (28), however near complete removal of this 100 
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information via spinal afferent blockade appears to impair the exerciser’s ability to select and 101 
maintain a physiologically optimal work rate (3). Spinal blockade studies show the 102 
importance of Group III and IV afferents to the performance of whole-body exercise (2, 3) 103 
but reveal less about the parallel effects of nociception and perceived pain on other systems 104 
such as cardiovascular control.  105 
 106 
Intramuscular hypertonic saline injection produces a muscle pain that feels like the naturally 107 
occurring EIP experienced during intense exercise (16, 50), and is therefore a useful method 108 
to investigate how EIP affects self-regulation of exercise intensity. This technique has 109 
previously been used in contralateral limb-matching tasks to assess the impact of tonic 110 
muscle pain on the judgement of torque in small muscle groups (40, 41, 57). In these studies, 111 
increased pain impeded the ability to accurately match torque, with pain intensity and degree 112 
of error correlating such that participants consistently overestimated the force generated by 113 
the painful muscle.  114 
 115 
This experimental approach could, however, be confounded by potential differences between 116 
the contralateral limbs (1, 36). To provide a more translatable assessment of the impact of 117 
EIP on whole-body exercise, the relationship between muscle pain and the reproduction of 118 
isometric torque production should be evaluated in the larger muscle groups of the lower limb 119 
such as the knee extensors, which have an important and fundamental role in the generation 120 
of force during locomotion and exercise. 121 
 122 
As such, the aim of the present study was to ascertain whether experimentally induced 123 
muscle pain in the vastus lateralis (VL) using an intramuscular injection of hypertonic saline 124 
would affect the ability to accurately gauge the torque produced by the knee extensor muscles 125 
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in a single-limb isometric torque reproduction task.  We tested the hypothesis that 126 
experimental muscle pain in the VL reduces torque reproduction accuracy (as quantified by 127 
the variance in mismatch between target and actual torque) of low intensity isometric 128 
contractions when compared to a placebo control condition.  129 
 130 
METHODS 131 
Ethical Approval  132 
All procedures and protocols were approved by the School of Sport and Exercises (University 133 
of Kent) Research Ethics Advisory Group (Prop 140_2016_17) in conformity with the 134 
Declaration of Helsinki, and its later amendments or comparable ethical standards. All 135 
participants were informed of the study experimental procedures, and written informed 136 
consent was obtained to confirm participation.   137 
 138 
Participants 139 
Fourteen healthy and recreationally active participants (13 male, 1 female; mean ± SD: age, 140 
25.3 ± 4.5 years; height 1.78 ± 0.1 m; body mass 73.9 ± 12.3 kg; physical activity 5.6 ± 2.2 141 
hours per week) volunteered to participate in the present study. Assuming a statistical power 142 
of 0.8 at an alpha level of 0.05, the sample size was estimated using G*Power software (13) 143 
based on the effect size reported in a similar study in our laboratory using hypertonic saline 144 
injections (50). All participants attended each visit in a similar psychological state as assessed 145 
by the Positive and Negative Affect Schedule (PANAS) (56), which was completed at the 146 
start of each visit.  147 
 148 
Before each visit, participants were instructed to refrain from vigorous exercise (24 h) and 149 
abstain from the consumption of alcohol (48 h), analgesics (6 h) and caffeine (8 h). 150 
7 
 
Participants with existing knee pain, cardiorespiratory disease, neurological disorders, blood 151 
borne viruses, sore deep tissues, phobia to needles and any allergy were excluded from the 152 
study. 153 
 154 
Experimental design 155 
In a two-way repeated-measures experimental design, participants performed an isometric 156 
torque matching and reproduction task with either pain (a single intramuscular injection of 157 
hypertonic saline) or a placebo control (a single intramuscular injection of isotonic saline) 158 
(condition factor). Participants attended a familiarisation session, and then completed the 159 
experimental conditions in a randomised and counterbalanced order, with each visit separated 160 
by a minimum of seven days. During the task participants attempted to produce torque at two 161 
set targets without the aid of real-time visual feedback before (Baseline), during (Pain/No 162 
Pain), and after (Recovery) the induction of pain and no pain (time factor). Measures of 163 
torque, rating of perceived effort (RPE), surface electromyography (sEMG) and heart rate 164 
(HR) were taken during each contraction. Pain intensity was recorded continuously using an 165 
electronic visual analogue scale (VAS) and pain quality through the completion of a McGill 166 
Pain Questionnaire (MPQ). A schematic of the experimental design and protocol is outlined 167 





Fig 1. Schematic overview of the experimental design and procedures. MVICs: maximal 171 
voluntary contractions 172 
 173 
 174 
Experimental Procedures 175 
Torque matching and reproduction task 176 
All visits were performed seated on an isokinetic dynamometer (Cybex HUMAC Norm 177 
isokinetic dynamometer; CSMi, Soughton, MA, USA) set up for the right leg, with the knee 178 
set at an angle of 75o of flexion (0o = full extension of the knee), and a hip angle of 90o. 179 
Torque matching and reproduction for knee extension were determined at isometric 180 
contractions of 15% and 20% maximal voluntary isometric torque (MVIT). These values 181 
were selected based on the percentage of MVIT utilised during maximal (100% maximal 182 
oxygen uptake; VO2MAX) and submaximal (70% VO2MAX) cycling exercise performed at a 183 
pedal rate between 60-80 revolutions per minute (24). At the start of each visit, participants 184 
completed 3×3 s maximum voluntary isometric contractions (MVICs) separated by 90 s rest, 185 
with the greatest instantaneous value taken as MVIT. If the MVIT of consecutive MVICs 186 
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were not within 5% of each other, additional MVICs were performed until this criteria was 187 
achieved.  188 
 189 
Participants attempted the target torques in a trial with real-time torque-production visual 190 
feedback (‘Feedback Trial’) and a trial without visual feedback (‘No Feedback Trial’). 191 
During the Feedback Trials, target torques (15% and 20% MVIT) were presented with actual 192 
torque produced via a computer display. Participants were instructed to remember muscular 193 
sensations experienced during each target torque and use these to reproduce the same torque 194 
in the subsequent No Feedback Trial (7). All Feedback and No Feedback trials were 195 
separated by a 3-minute period of rest.  196 
 197 
For each trial, participants performed four 6 s contractions separated by 4 s of rest in a 198 
randomised counter-balanced order, which provided two attempts at both target torques (i.e. 199 
2×15% MVIT, 2×20% MVIT). During each contraction, participants were instructed to try 200 
and match the target torque within the first 2 s, and then maintain it for a further 4 s.  201 
 202 
Intramuscular injection procedure 203 
A single bolus of 1.0 mL hypertonic saline (5.8%) was manually injected into the middle 204 
third of the VL of the right leg over a 20 s window (10 s infusion period). The injection was 205 
performed using a 3 mL Luer-Lok syringe connected to a 25 G × 38 mm SurGuard2 206 
disposable stainless needle (Terumo, Japan). In the control condition, a single bolus of 1.0 207 






Visit 1 – Familiarisation  212 
Participant anthropometric and descriptive measures of age, height, body mass, and hours of 213 
physical activity engaged in per week were recorded. Participants were then familiarised with 214 
the RPE and pain scales (8), as well as the performance of MVICs, and the Feedback/No 215 
Feedback Trials. Five minutes after the completion of the final MVIC, participants performed 216 
an initial Feedback Trial followed by a No Feedback Trial. Verbal confirmation of the actual 217 
torque produced in each contraction was given after the completion of the trial. All four 218 
contractions in the No Feedback Trial were required to be within 10% of target torque, with 219 
further No Feedback Trials completed until this was satisfied. The visit concluded upon the 220 
successful completion of a No Feedback Trial or following ten unsuccessful trials.  221 
 222 
Visits 2 & 3 – Experimental visits 223 
All participants completed a Control (isotonic saline) and an Experimental (hypertonic saline) 224 
condition in a randomised and counterbalanced order. In each condition, five-minutes after 225 
the completion of the MVICs, participants completed six trials (Feedback, No Feedback, 226 
Feedback, No Feedback, Feedback, No Feedback). Prior to the second No Feedback Trial, 227 
participants received an intramuscular injection of either isotonic (Control) or hypertonic 228 
saline (Experimental), with the No Feedback Trial beginning 20 s after the removal of the 229 
needle. This ensured that the 15% and 20% MVIT contractions in this No Feedback Trial 230 
were performed with a “moderate” to “strong” muscle pain intensity elicited from the painful 231 
hypertonic saline infusion. Ten minutes after the completion of this second No Feedback 232 






Perceptual and psychological measurements 237 
At the start of each visit participants rated the expected pain (0 = “no pain” to 10 = “worst 238 
possible pain”) and their confidence to cope with it (0 = “not confident at all” to 10 = 239 
“completely confident”). Muscle pain was evaluated by intensity and quality. Participants 240 
rated pain intensity on a moment-to-moment basis using an electronic VAS ranging from 0 241 
(“no pain”) to 10 (“extremely intense pain”). Participants were instructed to anchor the scale 242 
to previous experiences of EIP (4). The device recorded the reported pain value every 5 s, 243 
providing measures of pain for each individual contraction. In addition, onset pain intensity 244 
(VAS onset), maximal pain intensity (VAS peak), time to maximal intensity (VAS time to 245 
peak; from the commencement of sampling), mean pain intensity (VAS mean) and duration 246 
of pain (VAS duration; from VAS onset until the state of “no pain”) were also calculated 247 
using data from the electronic VAS.  248 
 249 
After the second No Feedback Trial, when pain had subsided, Total Pain Rating Index and 250 
Subclass Rating Index was calculated using a 78 item MPQ (29), with overall quality of pain 251 
described by descriptors (sensory, affective, evaluative and miscellaneous) chosen by more 252 
than one-third of participants. Upon the completion of each trial, participants provided a RPE, 253 
defined as the effort to drive the limb (32), of both target torques using the 15-point Borg (6-254 
20) scale (6).  255 
 256 
Physiological measurements 257 
Heart rate (HR) was recorded upon the completion of each individual contraction, and muscle 258 
electrical activity was continuously recorded using surface electromyography (sEMG). sEMG 259 
was attained through square surface electrodes (Ag/AgCl, 32 × 32 mm; Nessler 260 
Medizintechnik, Innsbruck, Austria) mounted in a bipolar set-up, and placed on the muscle 261 
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belly of the VL, vastus medialis (VM) and rectus femoris (RF). For each muscle a reference 262 
electrode was placed on the patella. Prior to application of the electrodes, the skin was shaven 263 
and cleansed with an alcohol swab. The electrical signal was sampled at 1000 Hz (Biopac 264 
MP150, Biopac Systems Inc., California, USA).  265 
 266 
Data analysis 267 
The sEMG and torque data (for analysis of torque output complexity) were analysed using 268 
custom code written in MATLAB 2018a (The MathWorks, Massachusetts, USA). 269 
 270 
Torque and error 271 
Torque was recorded through Spike2 software (Cambridge Electronics Design (CED), 272 
Cambridge, UK). For each 6 s contraction, the torque produced over the last 4 s was 273 
averaged. The average of the actual torque produced for each 15% and 20% target was used 274 
to define the error in participant torque reproduction. Error was defined as the unidirectional 275 
difference between the required target torque and the actual torque produced, and expressed 276 
as a percentage of MVIT (i.e. actual torque of 17.5% MVIT for the 15% MVIT target would 277 
be equal to an error of 2.5% MVIT). All values of error are presented as positive integers 278 
regardless of whether the participant over- or undershot the target torque. The pain on the 279 
VAS reported for the corresponding contractions were also averaged for the two attempts at 280 
each target torque to provide a mean VAS value for each target torque.  281 
 282 
Surface electromyography (sEMG) 283 
To create a linear envelope representation of the data, rectified absolute values of the raw 284 
sEMG signals were two-pass zero-lag filtered using a fourth-order low-pass Butterworth 285 
filter, with a cut-off frequency of 5 Hz. The amplitude for the VL, RF and VM were averaged 286 
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over the final 4 s period of each 6 s contraction. These values were normalised to the 287 
maximum amplitude of the prior MVICs (% MVIC). For each trial, the sEMG activity was 288 
averaged for the two contractions performed at each target torque.  289 
 290 
Torque complexity 291 
The complexity and regularity of the torque output was estimated through the use of 292 
approximate entropy (ApEn) and sample entropy (SampEn) (37, 43). When applied to 293 
physiological time-series data, ApEn is an index that quantifies the predictability or 294 
probability of the subsequent values based on prior values, whilst SampEn provides the same 295 
output but excludes self-matches (37, 43). Both ApEn and SampEn are defined by a value 296 
between 0 (‘high regularity, low complexity’) and 2 (‘low regularity, high complexity’).  A 297 
detailed guide to the algorithms for the calculation of ApEn are evidenced in the appendix of 298 
Slifkin and Newell (48), whilst SampEn was calculated using the parameters outlined by 299 
Pethick and colleagues (34).   300 
 301 
Statistical analysis 302 
To compare reproduction error between the Control and Experimental conditions at the three 303 
time-points (Baseline, Pain/No Pain, and Recovery), a Levene’s test was used to determine 304 
equality of variance for each normalised target torque (15% and 20% MVIT). Changes in 305 
HR, RPE, sEMG activity and complexity were evaluated using two-way Analysis of variance 306 
(ANOVA) with treatment factor with two fixed levels (Control, Experimental) and a repeated 307 
measures Time factor with two time-points (Baseline, Pain/No Pain). A two-way ANOVA 308 
with a treatment factor with two fixed levels (No Feedback, Feedback) and a repeated 309 
measures Time factor with two time-points (Baseline, Pain/No Pain) was also implemented to 310 
evaluate changes in complexity. When an interaction effect was observed, follow-up paired 311 
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samples t-tests were used to assess differences between conditions. Paired samples t-tests 312 
were also implemented to evaluate the differences between conditions for pain expectation 313 
and confidence, VAS scores, pre-test PANAS, and the change in torque produced in Baseline 314 
compared to the Pain/No Pain time-point. A Pearson Bivariate correlation was used to 315 
evaluate the correlation between torque error and VAS score reported during the Pain/No 316 
Pain contractions. Cohen’s guidelines of 0.1 (small), 0.3 (medium) and greater than or equal 317 
to 0.5 (large) were used to indicate the strength of correlation. 318 
 319 
All data was checked for the standard assumptions associated with the performance of the 320 
above statistical tests prior to analysis. Data that did not satisfy the Shapiro-Wilk test of 321 
normality (P<0.05) were logarithmically transformed. Results are presented as mean ± 322 
standard deviation (SD). Cohen’s d and partial eta square (ƞp
2) values are reported as 323 
measures of effect size. Statistical significance was accepted at an alpha level of P<0.05. All 324 
statistical analysis were completed using SPSS Statistics v25.0 (SPSS, IBM, New York, 325 
USA).  326 
 327 
RESULTS 328 
Experimental muscle pain 329 
As shown in Table 1, paired samples t-tests revealed a significant difference in VAS pain 330 
data between the Control and Experimental conditions. The pain experienced in Experimental 331 
was significantly greater in terms of the onset VAS pain reported, with a significantly longer 332 
time to peak, yet greater peak VAS pain compared to Control. The reported VAS pain in 333 
Experimental was also longer in duration, inducing a significantly greater mean VAS pain, 334 
equivalent to a “moderate” to “somewhat strong” muscle pain, and therefore producing a 335 




The pain experienced in Experimental was predominantly described in the sensory and 338 
evaluative dimensions of pain as “aching” (50% of participants), “throbbing” (43% of 339 
participants), “shooting” (36% of participants), “cramping” (36% of participants), “annoying” 340 
(36% of participants). This produced a mean Total Pain Index of 14 ± 8, with an overall 341 
Present Pain Intensity of 2.1 ± 0.7 (“discomforting”).  342 
 343 
During the Pain/No Pain trial, a paired samples t-test revealed no significant difference (t13=-344 
0.9, P=0.366, CI.95 -0.9, 0.3, d=0.1) in mean VAS between contractions performed at 15% 345 
MVIT (4.2 ± 1.9) and 20% MVIT (4.5 ± 2.2) in the Experimental condition. Each of the two 346 
target torques in the Pain/No Pain trial was therefore completed at a similar intensity of pain 347 
(Fig 2b. and Fig 3b.). 348 
 349 
Table 1. Summary VAS pain data across the entire duration of the Control and Experimental 350 
conditions 351 
 Control Experimental P 
VAS mean 0.8 ± 1.0 3.1 ± 1.0** <0.001 
VAS peak 1.6 ± 2.2 5.7 ± 1.7** <0.001 
VAS onset  0.5 ± 0.8 1.7 ± 1.3* 0.012 
VAS time to peak (s) 41 ± 29 71 ± 24* 0.020 
VAS duration (s) 55 ± 56 233 ± 60** <0.001 
VAS area 86.3 ± 115.4 759.8 ± 325.6** <0.001 
Values are means ± SD. **Significant difference between Control and Experimental (P < 352 
0.001). *Significant difference between Control and Experimental (P < 0.05). VAS scale 0 353 





Fig 2. Individual (open symbol) and group mean (filled symbol) perceptual differences 357 
between conditions (Control and Experimental) at Baseline, Pain/No Pain and Recovery 358 
time-points at a target torque of 15% MVIT. Differences in pain intensity after injection of 359 
isotonic saline (Control, a) and hypertonic saline (Experimental, b). Differences in RPE in 360 
Control (c) and Experimental (d) conditions. *Significantly greater where hypertonic saline 361 











Fig 3. Individual (open symbol) and group mean (filled symbol) perceptual differences 371 
between conditions (Control and Experimental) at Baseline, Pain/No Pain and Recovery 372 
time-points at a target torque of 20% MVIT. Differences in pain intensity after injection of 373 
isotonic saline (Control, a) and hypertonic saline (Experimental, b). Differences in RPE in 374 
Control (c) and Experimental (d) conditions. *Significantly greater where hypertonic saline 375 
was injected 376 
 377 
 378 
Paired samples t tests revealed no significant difference (t13=-1.8, P=0.096, CI.95 -2.08, 0.19, 379 
d=0.5) in expectations of pain between the Control (4.5 ± 2.1) and Experimental (5.4 ± 1.8) 380 
conditions, with no significant differences in the confidence to cope with the expected pain 381 
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(t13=0.2, P=0.818, CI.95 -0.29, 0.37, d=0.1) between Control (9.5 ± 1.0) and Experimental (9.4 382 
± 1.0).  383 
 384 
Comparisons of torque production accuracy 385 
In the presence of greater levels of pain, participants demonstrated an increased variability in 386 
their ability to reproduce target torque without visual feedback. However, once the pain had 387 
subsided, participants were able to produce the target torque with the same accuracy as 388 
Baseline. This is demonstrated by the Levene test for equality of variance, which revealed a 389 
significant difference in the variance of mean contraction torque in the Pain/No Pain trial 390 
between the Experimental and Control conditions at both 15% MVIT (F1,26=4.3, P=0.049, 391 
d=0.6) and 20% MVIT (F1,26=12.0, P=0.002, d=1.0), as shown in Figures 4 and 5. There was 392 
no correlation between Pain/No Pain error and the pain intensity  reported during the 393 
contractions (15% MVIT; r= -0.053, P=0.858, 20% MVIT; r=0.172, P=0.557). In addition, 394 
there was no significant difference in variance between conditions at the Baseline (15% 395 
MVIT; F1,26=0.2, P=0.612, d=0.1, 20% MVIT; F1,26=2.1, P=0.161, d=0.2) and Recovery 396 





Fig 4. Individual (open circle) and group mean (filled circle) torque reproduction error at a 400 
target torque of 15% MVIT before (Baseline), during (Pain/No Pain) and after (Recovery) 401 








Fig 5. Individual (open circle) and group mean (filled circle) torque reproduction error at a 408 
target torque of 20% MVIT before (Baseline), during (Pain/No Pain) and after (Recovery) 409 
injection of isotonic saline (Control, a) or hypertonic saline (Experimental, b). 410 
 411 
 412 
A paired samples t-test found no significant difference in the change in torque mismatch 413 
between Baseline and Pain/No Pain trials at 15% MVIT (t13=-1.5, P=0.169, CI.95 -1.1, 0.2, 414 
d=0.5) when comparing the Control (2.5 ± 1.7 %MVIT) and Experimental (4.8 ± 4.8 415 
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%MVIT) conditions. Furthermore, the paired samples t-test highlighted no significant 416 
difference in the same change in torque mismatch between Control (4.2 ± 3.5 %MVIT) and 417 
Experimental (7.4 ± 6.0 %MVIT) when contractions were performed at 20% MVIT (t13=-1.3, 418 
P=0.235, CI.95 -1.6, 0.4, d=0.4). This suggests that the target torque absolute error in the 419 
‘Pain/No Pain’ was similar to the error made at Baseline despite the change in pain 420 
experienced.  421 
 422 
Rating of perceived effort  423 
It was apparent that the effort experienced during the contraction was greater in the presence 424 
of increased pain, when performed at 20% MVIT. The 2 x 2 (condition x trial) repeated 425 
measures ANOVA demonstrated a significant interaction effect at 20% MVIT for RPE over 426 
trials between conditions (F1,13=6.0, P=0.030, ƞp
2=0.314). Follow-up paired samples t-tests 427 
revealed a significantly greater RPE (t13=-2.3, P=0.038, CI.95 -1.31, -0.04, d=0.3) in the 428 
Pain/No Pain trial in Experimental compared to Control. A significantly greater (t13=-2.4, 429 
P=0.033, CI.95 0.1, 1.8, d=0.4) RPE was also reported in the Experimental condition at the 430 
Pain/No Pain trial compared to the Baseline trial.  No significant main effect of condition was 431 
observed at either 15 or 20% MVIT (P>0.05). A significant effect of trial was reported at 432 
20% MVIT (F1,13=5.2, P=0.041, ƞp
2=0.284), but not at 15% MVIT (P>0.05) (Figs. 2c., 2d., 433 
3c. and 3d.). There was no interaction effect observed at 15% MVIT (P>0.05).  434 
 435 
Surface electromyography (sEMG) 436 
Due to excessive noise in sEMG signal, two participants were removed from the dataset and 437 
analysis was performed on the remaining participants (n=12). Despite a greater variance in 438 
mean contraction torque in the presence of muscle pain, there were no discernible alterations 439 
in activation of the agonist and synergist muscles. At 15 and 20% MVIT, the performance of 440 
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a 2 x 2 (condition x trial) repeated measures ANOVA demonstrated no significant main effect 441 
of condition or trial in either the VL, VM or RF (P>0.05). The VL, VM or RF also 442 
demonstrated no significant interaction effect for sEMG activity over trial between conditions 443 
at both target torques (P>0.05).  444 
 445 
Torque complexity 446 
As shown in Table 2, the presence of visual feedback resulted in a more complex (less 447 
regular) torque signal (assessed by both ApEn and SampEn) than when torque was being 448 
reproduced (No Feedback Trials) (P<0.001).  No condition (P>0.05) and no interaction 449 
effect was observed for either ApEn or SampEn (P>0.05) at both target torques. At 15 and 450 
20% MVIT, the performance of a 2 x 2 (condition x trial) repeated measures ANOVA 451 
demonstrated no significant main effect of condition for either ApEn or SampEn, as well as 452 
no significant main effect of trial for either complexity statistic (P>0.05). There was no 453 
interaction effect observed for either ApEn or SampEn (P>0.05) at both target torques. 454 
 455 
Heart rate (HR) 456 
The 2 x 2 (condition x trial) repeated measures ANOVA revealed no significant main effect 457 
of condition at 15 or 20% MVIT (P>0.05). At 15% MVIT there was no significant main 458 
effect of trial (P>0.05), however there was at 20% MVIT (F1,13=5.2, P=0.041, ƞp
2=0.284). No 459 
significant interaction effect for HR and trial between conditions was observed at 15 or 20% 460 







Table 2. Torque complexity (ApEn) during Feedback and No Feedback trials at the Baseline 466 
and Pain/No Pain time-points  467 
Condition Time-point Trial Target Torque 
15% MVIT 20% MVIT 
   ApEn SampEn ApEn SampEn 




























































































Values are means ± SD. * Significant difference between Feedback and No Feedback trial 468 







DISCUSSION  474 
The present study demonstrates for the first time that the experience of muscle pain, 475 
administered by the intramuscular injection of hypertonic saline into the VL, resulted in a 476 
greater variance in the mean contraction torque at both 15 and 20% MVIT when compared to 477 
the injection of isotonic saline (a placebo control). The increased variance was paralleled by 478 
an elevated experience of pain at both contraction intensities, and a greater perceived effort 479 
when performed at 20% MVIT. Once the pain had subsided, accuracy of torque production 480 
returned to baseline levels. This study for the first time demonstrates that the presence of 481 
muscle pain (that feels like EIP) impedes the ability to accurately reproduce torque in the 482 
knee extensors. This important finding provides key experimental evidence for the 483 
deleterious implications of EIP on the ability to self-regulate exercise intensity.  484 
 485 
Effect of pain on isometric torque reproduction 486 
 487 
The purpose of the present study was to establish whether the presence of pain in a muscle 488 
with a major contributing role to force generation during both dynamic contractions and 489 
whole-body exercise (i.e. the VL) has a debilitative effect on producing a given torque using 490 
the ipsilateral knee extensor muscle group. The primary finding from this study is that the 491 
mismatch between the actual torque produced and the target torque (when required to 492 
reproduce both 15 and 20% MVIT) was significantly more variable with pain, with no 493 
discernible direction of error (i.e. participants both under- and overshot the target torque). 494 
Resultantly, this study is the first to demonstrate that the experimental induction of pain in a 495 
large locomotor muscle group impairs the judgement of torque during an isometric 496 




The compromised ability to accurately reproduce torque during pain is in line with previous 499 
research that has implemented the hypertonic saline model in the elbow flexors to investigate 500 
the impact of pain on estimation error in a contralateral torque estimation task (40, 41, 57). 501 
However, this prior literature has consistently reported that participants specifically 502 
overestimated the torque that is produced in the painful muscle, and therefore produced less 503 
torque than required. In contrast with lack of direction in error reported in the present study, 504 
this observed disparity could be due to potential differences in the limb evaluated (e.g. 505 
contralateral or ipsilateral). Alternatively, as the knee extensor muscles respond differently to 506 
exercise-induced fatigue (55), the muscle group tested (elbow flexor vs. knee extensors) 507 
should also be considered.  508 
 509 
Proposed mechanisms 510 
The presence of the hypertonic saline solution in addition to the short-duration muscle 511 
contraction creates a noxious environment within the skeletal musculature (31), which results 512 
in an alteration in activity of both ascending metaborecptive and nociceptive group III and IV 513 
afferent fibers (18). In this noxious environment, there are several neuromuscular 514 
mechanisms that, when acting in singularity or in combination, may provide an explanation 515 
for the impaired reproduction of torque in the present study.  516 
 517 
Convergent projection from group III and IV afferents on common interneurons from group 518 
Ib proprioceptive afferents (45) provide information on muscle force (15). As discussed by 519 
Salomoni and Graven-Nielsen (44), the large variance in the mean contraction torque in the 520 
Experimental condition could be a result of the spatial facilitation between these afferents 521 
interfering in the central interpretation of proprioceptive information essential for the 522 
accurate control of torque. A discrepancy between the centrally mediated judgement of 523 
26 
 
torque and the actual afferent feedback from the periphery could therefore have resulted in 524 
the torque reproduction error.   525 
 526 
In addition, the projection of the group III and IV afferents have inhibitory effects on the 527 
central nervous system. The increased afferent feedback from the hypertonic saline may have 528 
limited motor cortical excitability, and reduced central motor drive and voluntary activation 529 
of the knee extensors (14, 19). In order to compensate for the hypertonic saline-induced 530 
impairment of motor cortex excitability, a greater effort is required to drive the limb to meet 531 
the required torque (30, 39). As an outcome reflected in the present study, this could provide 532 
a possible explanation for some of the differences in actual and perceived torque produced. 533 
The findings from Proske and colleagues (40) where the matching of torque through effort 534 
resulted in an overshoot of the target torque, are in support of this explanation.  535 
 536 
Despite the observed impairment in torque-reproduction performance during pain, there was 537 
no change in the torque complexity of the knee extensors, or the level of muscle activity 538 
assessed by sEMG. The absence of alterations in sEMG is comparable with findings from the 539 
established literature into the implications of EIP on muscle activity during submaximal 540 
isometric contractions, where a lack of marked changes in sEMG signal are also observed 541 
(16, 44, 46).  Combined, these observations contradict the underpinning theory of the ‘Pain 542 
Adaptation Model’ (25) where it is predicted that the presence of pain has a reliable 543 
inhibitory influence on agonist muscles, whilst simultaneously activating the antagonists. 544 
Instead, the observations of the present study could, with caution, be in-line with the “moving 545 
differently in pain” model proposed by Hodges and Tucker (17). This theory postulates that 546 
pain initiates a non-uniform effect across the motor neurone pool, causing a redistribution of 547 
activity between and within muscles to provide a key adaptive and protective function. Whilst 548 
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this alteration has the immediate benefit of minimising the pain experienced and preventing 549 
further injury or damage to the area in pain during muscular contraction, this change to a 550 
“sub-optimal” movement strategy could have consequences for the efficiency of task 551 
performance (17, 53). Detection of these adaptations would however require the use of fine-552 
wire electrodes (52) or high density sEMG, as a combination of changes in order of motor 553 
unit activation or synchronisation can occur without alteration in amplitude of gross sEMG 554 
(51). 555 
 556 
A loss of knee-extensor torque complexity during both prolonged maximal and submaximal 557 
contractions has been closely associated with fatigue (34, 35), and is suggested to have a 558 
detrimental impact on the performance of motor tasks in the lower limb (10). In the present 559 
study, the lack of change in torque complexity suggests that the acute pain from the 560 
hypertonic saline was unlikely to have independently caused neuromuscular fatigue. The 561 
increased variance in mean contraction torque is therefore unable to be explained by pain-562 
induced mechanisms of fatigue during the short-duration and submaximal isometric 563 
contractions.  564 
 565 
This finding is consistent with prior literature, where differences in torque complexity are not 566 
observed in the first few seconds of isometric muscle contraction despite the presence of pain 567 
(from an eccentric contraction muscle damage protocol) and the consequential impaired 568 
ability to perform a maximal voluntary contraction (33). As torque complexity progressively 569 
decreases over time during submaximal contractions until the point of task failure (34), if the 570 
torque reproduction task in the present study was performed over a longer duration, a pain-571 
induced acceleration of exercise-induced fatigue (and therefore loss of torque complexity) 572 
would likely be observed in addition to the impaired the ability to accurately reproduce 573 
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torque. As such the findings of the present study reinforce the notion that acute, moderate 574 
muscle pain alone is not necessarily fatiguing, but may accelerate the development of fatigue 575 
during prolonged or exhaustive exercise (27, 50), or impair maximal voluntary contraction.  576 
 577 
A further point of consideration is that in the absence of visual feedback, and sole reliance on 578 
afferent/efferent information and task memory, the ability to accurately reproduce torque 579 
depreciates (22) and that this is characteristically coupled with a lower complexity of the 580 
torque signal (indicative of a reduced adaptability in force control) (21, 49). This observation 581 
is replicated in the present study, and it is noteworthy that the values for ApEn and SampEn 582 
in the No Feedback conditions are similar to those shown at task failure in exhaustive 583 
exercise (34). Therefore, it is possible that the induction of muscle pain in the present study 584 
was not able to reduce the complexity of the torque signal beyond that already caused by the 585 
removal of visual feedback.  586 
 587 
Alternatively, the compromised ability to accurately reproduce torque (despite no change in 588 
loss of torque complexity) could be due to the experience of pain preventing some attentional 589 
focus on the task (23), making the task more challenging. It is plausible that the elevated 590 
intensity of pain (induced by the injection of hypertonic saline), which was rated as 591 
“moderate” to “somewhat strong” in both target torques, provided a stimulus which was 592 
perceived as threatening. With some attentional resources focused on coping with the ‘threat’ 593 
of the noxious stimuli, attention may have been directed away from the task, which could 594 
have resulted in a compromised accuracy of torque reproduction (11); a notion supported by 595 
evidence from previous experimental work (5, 26). However, in the current study, there was 596 
no relationship between pain intensity and error, which indicates that the sensation of pain 597 




Overall, it is evident that the presence of pain interferes with proprioception during 600 
submaximal isometric contractions in the lower-limb. The design and findings of the present 601 
study therefore provide a key indication of the potential mechanism underpinning the 602 
detrimental effect of EIP on exercise intensity regulation and endurance performance. Some 603 
caution should however be taken when extrapolating these findings to whole-body exercise. 604 
In order to improve task relevance to whole-body locomotor exercise and further apply the 605 
findings of the present study, there is the need for the impact of this experimental model to be 606 
evaluated during isokinetic or dynamic muscular contractions performed at a varying or 607 
higher work rate.  608 
 609 
Methodological considerations 610 
Whilst there is inconsistent evidence for sex-related differences in the pain intensity response 611 
to the hypertonic saline model (20, 42), the fluctuations in hormone concentration across the 612 
different menstrual cycle phases may cause differences in pain perception to experimental 613 
pain (47). It is acknowledged that the present study did not account for menstrual cycle 614 
phases of the female participant, and this is a limitation. It is also important to note that the 615 
short-duration and submaximal isometric contractions used in the current study were not 616 
fatiguing, and this limits the ability to examine the notion that pain accelerates the 617 
development of exercise-induced fatigue in addition to the impairment in accurate torque 618 
reproduction. To explore this in combination, future investigations should attempt to employ 619 
a similar study design examining torque reproduction ability in the presence of muscle pain 620 
during contractions performed at a greater exercise intensity, or over a longer duration.  621 
 622 
Conclusion  623 
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In conclusion, the injection of hypertonic saline into the VL during a torque reproduction task 624 
created muscle pain that resulted in an impaired ability to accurately produce a given 625 
submaximal target torque during a short, submaximal isometric contractions. The presence of 626 
pain was linked with a greater effort to drive the limb and meet the given target torque when 627 
attempting to contract at 20% MVIT, but not at 15% MVIT. The compromised ability to 628 
reproduce torque returned to baseline levels once pain had subsided. These findings have 629 
implications for the impact of EIP on self-selected work rate regulation during endurance 630 
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